Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Cerus Corporation    CERS

CERUS CORPORATION (CERS)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/08/2018 10/09/2018 10/10/2018 10/11/2018 10/12/2018 Date
6.31(c) 6.16(c) 5.85(c) 5.89(c) 5.99(c) Last
607 921 846 332 1 004 331 1 389 920 695 867 Volume
-2.77% -2.38% -5.03% +0.68% +1.70% Change
More quotes
Financials (USD)
Sales 2018 74,2 M
EBIT 2018 -52,0 M
Net income 2018 -54,3 M
Finance 2018 58,6 M
Yield 2018 -
Sales 2019 99,8 M
EBIT 2019 -44,3 M
Net income 2019 -46,3 M
Finance 2019 20,3 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 10,0x
EV / Sales2019 7,83x
Capitalization 802 M
More Financials
Company
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products.It produces blood system for platelets and plasma.It markets its products under the INTERCEPT brand.The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
10/15 | 10:30pmPresentation
More about the company
Surperformance© ratings of Cerus Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CERUS CORPORATION
10/12CERUS : Announces Schedule of Presentations at the 2018 AABB Annual Meeting
BU
10/11CERUS : Dr. Laurence Corash Recognized With the Prestigious Dale A. Smith Memori..
BU
10/11CERUS : Appoints Eric Bjerkholt to Board of Directors
AQ
10/09CERUS CORP : Change in Directors or Principal Officers, Financial Statements and..
AQ
10/09CERUS : Appoints Eric Bjerkholt to Board of Directors
BU
10/02CERUS : to Host Institutional Investor Meeting
BU
09/26CERUS : to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
BU
09/06CERUS CORP : Change in Directors or Principal Officers, Financial Statements and..
AQ
09/06CERUS : Appoints Timothy L. Moore to Board of Directors
BU
08/30CERUS : to Present at the Baird 2018 Global Healthcare Conference
BU
More news
Sector news : Medical Devices & Implants
11:41aConvaTec shares plunge on profit warning and CEO departure
RE
10/10MEDTRONIC : Gets Regulatory Approval for Insulin Pump
DJ
10/05ESSILORLUXOTTICA : Italy' antitrust opens probe over Luxottica's acquisition of ..
RE
10/04Smiths Group to buy aircraft engine parts maker United Flexible in $345 milli..
RE
10/03ABBOTT LABORATORIES : Companies Lure New Workers With College Coaching, Student ..
DJ
More sector news : Medical Devices & Implants
Latest Tweets
10/12Cerus Announces Schedule of Presentations at the 2018 AABB Annual Meeting  
10/12$CERS Cerus - Cerus Announces Schedule of Presentations at the 2018 AABB Annu.. 
10/12$CERS Cerus - 4 (Statement of Changes in Beneficial Ownership) SEC Filing Fro.. 
10/11$CERS Cerus - Dr. Laurence Corash Recognized With the Prestigious Dale A. Smi.. 
10/10Cerus Appoints Eric Bjerkholt to Board of Directors  
More tweets
Qtime:23
News from SeekingAlpha
09/27Small Companies With Superior Growth And Strong Momentum 
08/02Cerus Corporation (CERS) CEO Obi Greenman on Q2 2018 Results - Earnings Call .. 
08/02Cerus beats by $0.01, misses on revenue 
08/01Notable earnings after Thursday?s close 
05/16Cerus nabs $15M government contract 
Chart CERUS CORPORATION
Duration : Period :
Cerus Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CERUS CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 9,13 $
Spread / Average Target 52%
EPS Revisions
Managers
NameTitle
William Mariner Greenman President, Chief Executive Officer & Director
Daniel N. Swisher Chairman
Suzanne Margerum Vice President-Manufacturing & Operations
Kevin Dennis Green Chief Financial Officer & Vice President-Finance
Laurence M. Corash Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
CERUS CORPORATION77.22%788
STRYKER CORPORATION10.46%63 100
SMITH & NEPHEW0.58%14 991
WRIGHT MEDICAL GROUP NV20.79%3 342
GLAUKOS CORP129.47%1 995
JAPAN LIFELINE CO., LTD.-8.41%1 746